
FDA Approves Third Use of Bayer’s Nubeqa for Advanced Prostate Cancer
FDA Grants New Approval for Bayer’s Nubeqa™ (Darolutamide) in Treating Advanced Prostate Cancer Bayer today announced a significant milestone in the treatment of prostate cancer, revealing that the U.S. Food and Drug Administration (FDA) has approved an expanded use of…














